Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human Trial

Conditions

• Idiopathic Pulmonary Fibrosis (IPF)

Interventions

• DRUG: Dasatinib + Quercetin
• DRUG: Placebo

Sponsor

Wake Forest University Health Sciences

Collaborators

• [object Object]
• [object Object]